To investigate whether the increase in mitochondrial respiration upon SHIP1 inhibition impacts ROS levels in CLL, we measured levels of cellular ROS upon SHIP1 inhibition and indeed observed that the high levels of ROS in primary CLL cells51 were further increased by 3AC treatment (Fig. 5f). Here, INPP5D is linked to B-cell chronic lymphocytic leukemia.